Viking Therapeutics (VKTX) Valuation Check After Recent Share Price Swings And Analyst Fair Value Gap [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Viking Therapeutics: recent share performance and business profile Viking Therapeutics (VKTX) has drawn attention after a 4.7% move over the past day, adding to mixed returns over the past month and past 3 months as investors reassess the clinical-stage biotech story. The San Diego based company focuses on metabolic and endocrine disorders, with a pipeline that includes VK2809 for non-alcoholic steatohepatitis and VK2735 targeting glucagon-like peptide 1, along with several other candidates in Phase II trials. See our latest analysis for Viking Therapeutics. That latest 4.7% 1 day share price gain to US$32.98 comes after a 16% 30 day share price return but a 7% decline year to date, while the 1 year total shareholder return of 13% sits against a very large 3 year total shareholder return. This suggests long term holders have experienced strong momentum even as shorter term sentiment has cooled. If Viking's recent swings have you thinking about where growth elsewhere could c
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- Is Analyst EPS Reset Amid Outreach Efforts Altering The Investment Case For Viking Therapeutics (VKTX)? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (VKTX) was upgraded by BTIG Research to "strong-buy".MarketBeat
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- 1/26/26 - Form 4
- VKTX's page on the SEC website